ANI PHARMACEUTICALS, INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
ANI PHARMACEUTICALS, INC (ANIP) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 0 shares for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-05-05.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2015-05-05
- ANI PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2015-03-31 was 0.00 shares.
- ANI PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2014-12-31 was -4.00K shares.
- ANI PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2014-09-30 was 4.00K shares.
- ANI PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2014-06-30 was 60.00K shares.
- ANI PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2014 was 60.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month |
|---|---|---|---|---|
| 2015-03-31 | 0.00 shares 10-Q · filed 2015-05-05 | -4.00K shares derived: sum of 2 quarters · filed 2015-05-05 | 0.00 shares derived: sum of 3 quarters · filed 2015-05-05 | 60.00K shares derived: sum of 4 quarters · filed 2015-05-05 |
| 2014-12-31 | -4.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-23 | 0.00 shares derived: sum of 2 quarters · filed 2015-02-23 | 60.00K shares derived: sum of 3 quarters · filed 2015-02-23 | 60.00K shares 10-K · filed 2015-02-23 |
| 2014-09-30 | 4.00K shares 10-Q · filed 2014-11-10 | 64.00K shares derived: sum of 2 quarters · filed 2014-11-10 | 64.00K shares 10-Q · filed 2014-11-10 | |
| 2014-06-30 | 60.00K shares 10-Q · filed 2014-08-07 | 60.00K shares 10-Q · filed 2014-08-07 | ||
| 2014-03-31 | 0.00 shares 10-Q · filed 2015-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |